Vitamin K2 – Softgel
- Helps your bones use calcium more effectively
- Supports normal blood clotting and cardiovascular health
- Soy free
- Vegan formula and softgel
- Carrageenan free
$29.94 — or subscribe and save 20%
Vitamin K is an essential vitamin needed for cardiovascular, bone, and liver health. Vitamin K2 breaks down into two forms, namely MK-4 and MK-7. While MK-4 is the active form of vitamin K2 used by the body, MK-7 has recently been shown to provide good results at low doses. AOR’s Vitamin K2 offers both forms of vitamin K2 in equal amounts, while most formulas on the market only focus on one or the other.
Unique to many other supplements, AOR’s Vitamin K2 is derived from soy-free sources for potential dietary concerns. Vitamin K2 is also formulated in a carrageenan-free Vegan Softgel, offering optimal absorption and suitability for various dietary preferences or restrictions, while promoting environmental sustainability.
Vitamin K2 from AOR™ provides MK-4 and MK-7, the two optimal forms of Vitamin K2 that help maintain bone health. Formulated using AOR’s patent pending VSoftgel™ technology for superior absorption. Vitamin K2 enhances calcium absorption into the bones.
AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, corn, nuts, peanuts, sesame seeds, mustard, dairy, sulphites, eggs, soy, fish, shellfish or any animal byproduct.
Take one softgel daily with or without food, or as directed by a qualified health care practitioner.
Consult a health care practitioner prior to use if you are taking blood thinners.
The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.
Non-medicinal Ingredients: organic coconut oil, microcrystalline cellulos. VSoftgel: purified water, glycerin, tapioca starch, sunflower vitamin E tocopherols.
In a 2006 review, authors Iwamoto et al. discussed the evidence that vitamin K2 reduces the incidence of fractures within the spinal vertebrae in postmenopausal women with osteoporosis. Although K2 has only modest effects on bone mineral density in these women, researchers have found that combining K2 with conventional osteoporosis medication (bisphosphonates), treatment may be more effective than with medication alone.
In a 2013 clinical trial, 244 healthy postmenopausal women were given either 180mcg of vitamin K2 or placebo daily for 3 years. Those given K2 showed decreased declines in bone mineral density (slower bone loss) in the hip and low back spine.
In a 2015 double-blind, randomized, controlled trial, researchers sought out to determine the effect of vitamin K2 on cardiovascular health. 244 healthy postmenopausal women were randomised to receive either 180mcg of vitamin K2 (MK-7) or placebo for 3 years. At the end of the treatment period the group that had been on K2 had significantly decreased arterial stiffness. The effect was greatest in women who started the study with high levels of stiffness, as K2 was able to decrease those measurements by 50% compared to placebo.